World Health & Population

World Health & Population 16(4) June 2016 : 5-8.doi:10.12927/whp.2016.24670

Negotiating Pharmaceutical Prices: A Change in Chinese Health Policy

Michael M. Costello


Like many other nations, China believed the key to restricting national health expenditures for pharmaceuticals was the use of governmentally imposed price caps. Given the recent growth in pharmaceutical expenditures, China is moving away from price caps to a new process that includes locally negotiated prices in the hope that such price competition will lower national pharmaceutical pricing. The success of this policy endeavour will depend significantly on managing other aspects of pharmaceutical purchasing.



Be the first to comment on this!

Note: Please enter a display name. Your email address will not be publically displayed